Modularity of the Metabolic Gene Network as a Prognostic Biomarker for Hepatocellular Carcinoma

Oncotarget - United States
doi 10.18632/oncotarget.24551
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Identification of CELSR2 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Updated Study on Action Mechanisms of Cereblon as a Novel Prognostic Biomarker for Hepatocellular Carcinoma

HPB
HepatologyGastroenterology
2019English

Circular RNA Hsa_circ_0078602 May Have Potential as a Prognostic Biomarker for Patients With Hepatocellular Carcinoma

Oncology Letters
Cancer ResearchOncology
2018English

SLC2A2 (GLUT2) as a Novel Prognostic Factor for Hepatocellular Carcinoma

Oncotarget
Oncology
2017English

Aberrant Upregulation of 14-3-3σ and EZH2 Expression Serves as an Inferior Prognostic Biomarker for Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2014English

Plasma Osteopontin as a Novel Diagnostic Biomarker for Early Detection of Hepatocellular Carcinoma.

International Journal of Advanced Research
2017English

Prognostic Factors for Hepatocellular Carcinoma Recurrence

World Journal of Gastroenterology
MedicineGastroenterology
2014English

Dynamic Network Biomarker Indicates Pulmonary Metastasis at the Tipping Point of Hepatocellular Carcinoma

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2018English

Prognostic Value of Aspartate Aminotransferase to Platelet Ratio Index as a Noninvasive Biomarker in Patients With Hepatocellular Carcinoma: A Meta-Analysis

Cancer Management and Research
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy